338 related articles for article (PubMed ID: 12717374)
21. Distant cutaneous metastasis preceding the diagnosis of ductal cholangiocarcinoma.
Stergiopoulos C; Kountouras J; Kapetanakis N; Katsinelos P; Kokkali S; Tsapournas G; Zavos C; Zaramboukas T
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):242-3. PubMed ID: 18554225
[No Abstract] [Full Text] [Related]
22. [Cholangiocellular carcinoma (intrahepatic bile duct carcinoma)].
Tarao K; Tamai S; Ohkawa S; Miyakawa K; Aoki H
Ryoikibetsu Shokogun Shirizu; 1995; (7):476-9. PubMed ID: 8749530
[No Abstract] [Full Text] [Related]
23. Hilar cholangiocarcinoma: pathology and tumor biology.
Kuang D; Wang GP
Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142
[TBL] [Abstract][Full Text] [Related]
24. Cholangiocarcinoma.
Mosconi S; Beretta GD; Labianca R; Zampino MG; Gatta G; Heinemann V
Crit Rev Oncol Hematol; 2009 Mar; 69(3):259-70. PubMed ID: 18977670
[TBL] [Abstract][Full Text] [Related]
25. Unusual para-neoplastic manifestation of cholangiocarcinoma.
Raza A; Houk L; Yousaf W; Smiley D; Coberly L
J Gastrointest Cancer; 2013 Jun; 44(2):228-30. PubMed ID: 22903498
[No Abstract] [Full Text] [Related]
26. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
27. Management and extent of resection for intrahepatic cholangiocarcinoma.
Carpizo DR; D'Angelica M
Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813
[TBL] [Abstract][Full Text] [Related]
28. The role of radiation therapy in intrahepatic cholangiocarcinoma.
Metz JM
Cancer J; 2006; 12(2):102-4. PubMed ID: 16630398
[No Abstract] [Full Text] [Related]
29. A case of mucin-producing cholangiocarcinoma.
Matsuba H; Sakamoto Y
Jpn J Clin Oncol; 2009 Jul; 39(7):467. PubMed ID: 19553400
[No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Advances in the Multidisciplinary Management of Intrahepatic Cholangiocarcinoma.
Cloyd JM; Ejaz A; Pawlik TM
Ann Surg Oncol; 2020 Aug; 27(8):2866-2867. PubMed ID: 32444910
[No Abstract] [Full Text] [Related]
31. Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma.
Ruff SM; Diaz DA; Pitter KL; Hartwell BC; Pawlik TM
CA Cancer J Clin; 2023; 73(4):346-352. PubMed ID: 37046405
[No Abstract] [Full Text] [Related]
32. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
Balsano C; Conti B; Arciello M
Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009
[No Abstract] [Full Text] [Related]
33. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
35. Transpapillary biliary biopsy for early stage cholangiocarcinoma of the distal common bile duct.
Asada M; Yazumi S; Yoshimoto T; Tamaki H; Matsuura M; Hasegawa K; Uenoyama Y; Hisatsune H; Nishio A; Chiba T
Gastrointest Endosc; 2006 Jul; 64(1):125-6; discussion 126. PubMed ID: 16813820
[No Abstract] [Full Text] [Related]
36. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
[TBL] [Abstract][Full Text] [Related]
37. Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation.
DeMorrow S
Dig Liver Dis; 2009 Feb; 41(2):164-5. PubMed ID: 19112054
[No Abstract] [Full Text] [Related]
38. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma--what level of evidence should we have?
Abrams RA
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):1-2. PubMed ID: 19100917
[No Abstract] [Full Text] [Related]
40. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
